Saturday
SESSION XXVII: NEW DEVELOPMENTS IN THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS: OPEN, EVAR, LAPAROSCOPIC AND OTHER TECHNIQUES (6 AND 7-MINUTE TALKS)
SESSION XXVII SCHEDULE
6:40 AM - 6:47 AM Update On Robotics And Robot-Assisted Laparoscopic Vascular Surgery: Its Main Value Is Not For Operations On The Aorta But For Other Vascular Procedures
  Presenters(s): Willem Wisselink, M.D.  
6:48 AM - 6:55 AM Current Limitations Of Laparoscopic AAA Surgery: What Can And Cannot Be Done
  Presenters(s): Olivier A. GoŽau-BrissonniŤre, M.D., Ph.D.  
6:56 AM - 7:03 AM Debate: The Case For Open Repair Of AAAs
  Presenters(s): Philippe Piquet, M.D.  
7:04 AM - 7:11 AM Debate: There Is No Case For Open Repair Of AAAs: EVAR Is Always The Preferred Treatment
  Presenters(s): James May, M.D., M.S., F.R.A.C.S., F.A.C.S.  
7:12 AM - 7:19 AM The EVAR II Trial Shows That The Intention To Treat By EVAR Confers No Benefit In High Risk AAA Patients But Fails To Show That EVAR Should Not Be Performed In Patients Deemed Unfit For Open Repair
  Presenters(s): Geoffrey L. Gilling-Smith, M.S., F.R.C.S.  
7:20 AM - 7:27 AM How Does One Make A Patient Unfit For Open Repair Fit For EVAR?
  Presenters(s): Michael L. Marin, M.D.  
7:28 AM - 7:35 AM Update On Methods To Prevent Abdominal Compartment Syndrome With EVAR For Ruptured AAA
  Presenters(s): Dieter O. Mayer, M.D. / Mario Lachat, M.D.  
7:36 AM - 7:45 AM Panel Discussion
Moderator(s): Roger M. Greenhalgh, M.D. / Wesley S. Moore, M.D.  
7:45 AM - 7:51 AM What Percent Of Ruptured AAAs Can Be Treated Endovascularly If EVAR Is Used Preferentially And Is It Cost Effective?
  Presenters(s): Eric L.G. Verhoeven, M.D., Ph.D.  
7:52 AM - 7:58 AM EVAR Should Be The Gold Standard For Treatment Of Ruptured AAAs: All Vascular Surgeons Should Be Prepared To Do It And Do It Right
  Presenters(s): Frank J. Veith, M.D.  
7:59 AM - 8:05 AM EVAR Is No Better Than Open Repair For Ruptured AAAs
  Presenters(s): Jacob Buth, M.D.  
8:06 AM - 8:12 AM Debate: EVAR For Ruptured AAAs May Be Attractive But It Should Be Restricted To Stable Patients And We Need A Randomized Trial To Prove Superiority
  Presenters(s): Marc R.H. van Sambeek, M.D., Ph.D.  
8:13 AM - 8:19 AM Debate: EVAR Is Feasible In Stable And Unstable Patients With Ruptured AAAs And Reduces Mortality: We Donít Need A Randomized Study
  Presenters(s): Manish Mehta, M.D., M.P.H.  
8:20 AM - 8:26 AM EVAR Is A Proven Treatment For Ruptured AAAs And Is Most Effective In Unstable Patients
  Presenters(s): Randy D. Moore, M.D.  
8:27 AM - 8:33 AM Consequences Of Early And Late Open Conversion Following EVAR: How To Make It Less Morbid
  Presenters(s): Wesley S. Moore, M.D.  
8:34 AM - 8:40 AM Five-Year Follow-up Of EVAR Patients Increases The Global Cost 50%
  Presenters(s): W. Charles Sternbergh III, M.D.  
8:40 AM - 8:48 AM Panel Discussion
END OF SESSION XXVII